Syndicated Research Studies

The global in vitro diagnostic (IVD) packaging market was valued at USD 9.30 billion in 2024 and is projected to reach USD 12.53 billion by 2030, expanding at a CAGR of 5.1% from 2025 to 2030. Market growth is driven by the rising adoption of multi-featured human-machine interface (HMI) devices, the increasing penetration of the Industrial Internet of Things (IIoT), and the widespread use of smart industrial displays. In addition, stringent regulatory requirements governing the safe handling and transport of diagnostic samples are accelerating market expansion. The IVD packaging sector continues to grow alongside the rising demand for diagnostic testing, which has increased significantly due to global health challenges such as the COVID-19 pandemic. The increasing prevalence of infectious and chronic diseases, combined with a global shift toward preventive healthcare, is leading to greater investment in diagnostic solutions. As test volumes climb, manufacturers are scaling the produc...

The global power tools market was valued at USD 32.95 billion in 2024 and is projected to reach USD 54.50 billion by 2030, reflecting a CAGR of 9.4% from 2025 to 2030. As governments worldwide continue to invest in large-scale infrastructure development, the demand for power tools used across construction activities is expected to rise steadily over the coming years. These initiatives are likely to spur substantial investments in non-residential construction, further strengthening the outlook for power tools. The U.S. market dominated with an 86.4% share in 2024, supported by continuous growth in construction, the increasing popularity of DIY activities, and greater adoption of power tools across industrial and manufacturing sectors. Overall, U.S. demand is anticipated to remain strong, fueled by multiple end-use industries and expanding consumer engagement. Cordless power tools are gaining widespread traction among both professionals and consumers. Battery-operated tools—inclu...

The global post-consumer recycled (PCR) plastics market was valued at USD 11.78 billion in 2024 and is projected to reach USD 21.64 billion by 2030, expanding at a CAGR of 10.4% from 2025 to 2030. This growth is largely driven by rising environmental concerns and increasingly stringent plastic waste management regulations that are pushing industries toward more sustainable production and consumption models. Corporate commitments to sustainability and government-led initiatives supporting circular economy practices are further accelerating the adoption of PCR plastics. These materials are gaining substantial traction across sectors such as packaging, automotive, and construction as companies aim to reduce their environmental impact and integrate recycled materials into product designs. Post-consumer recycled plastics are derived from consumer-used and discarded plastic products that undergo collection, sorting, and reprocessing to produce new materials. Several factors are strongly i...

The global polymethyl methacrylate (PMMA) market size was valued at USD 5.91 billion in 2024 and is expected to reach USD 10.01 billion by 2033 , expanding at a CAGR of 6.2% from 2025 to 2033 . One of the leading contributors to this growth is the rising demand for lightweight and fuel-efficient vehicles within the automotive sector. The automotive and transportation industries continue to play a pivotal role in driving PMMA adoption, as manufacturers increasingly seek materials that enhance fuel efficiency, offer design flexibility, and improve overall performance. PMMA—commonly referred to as acrylic or acrylic glass—is used extensively in headlamps, taillights, dashboards, windshields, and interior trims, serving as an attractive alternative to glass and polycarbonate. Its high optical clarity, strong UV stability, and excellent weather resistance make it a preferred material for automakers aiming to merge functionality with advanced aesthetics. As global automakers a...

The global point of use water treatment systems market was valued at USD 31.90 billion in 2024 and is projected to reach USD 53.56 billion by 2030, expanding at a CAGR of 9.2% from 2025 to 2030. Growing concerns surrounding waterborne infections such as E. coli and cholera have significantly increased global demand for point of use water purification solutions. According to a 2024 report by EBSCO, nearly 2 billion people still lack access to safe drinking water in their homes, while waterborne diseases contribute to 4% of the global disease burden. Approximately 2 million deaths occur each year due to waterborne diarrheal illnesses. Additionally, 1.3 to 4 million cholera cases are reported annually, leading to an estimated 21,000 to 143,000 deaths. In the U.S., regulations such as the Safe Drinking Water Act of 1974 and the Clean Water Act have established standards for drinking water quality, with the Environmental Protection Agency (EPA) implementing financial and technical program...

The global immersive technology market size was valued at USD 40.88 billion in 2024 and is projected to reach USD 169.88 billion by 2030, expanding at a CAGR of 27.9% from 2025 to 2030. Market growth is fueled by rapid advancements in augmented reality (AR) and virtual reality (VR), rising demand for enriched digital experiences across entertainment and gaming, and increasing investments in immersive platforms and devices. The increasing popularity of social VR platforms that support virtual interaction is expected to further accelerate market expansion. Growing smartphone adoption, supported by enhanced processing capabilities, is enabling higher accessibility to immersive applications, especially in media, entertainment, and education. Businesses across sectors are using immersive technologies to enhance collaboration, improve training outcomes, and optimize operational processes. Industries such as manufacturing are leveraging AR and VR for simulations, real-time data visualizatio...

The global immunotherapy drugs market size was valued at USD 257.6 billion in 2024 and is projected to reach USD 486.36 billion by 2030, expanding at a CAGR of 11.2% from 2025 to 2030. Growth in this market is largely driven by the rising global incidence of chronic diseases. According to the International Diabetes Federation (IDF), around 537 million adults aged 20–79 were living with diabetes in 2021, a number expected to increase to 783 million by 2045. In addition, major industry players are actively developing new products and forming strategic collaborations to accelerate research in immunotherapy treatments. A surge in chronic illnesses—particularly cancer—combined with the increasing preference for therapies that strengthen the immune system is boosting market growth. Immunotherapy offers a promising approach compared to conventional treatments, as it can selectively target diseased cells while reducing side effects. Key categories of immunotherapy drugs incl...